- Country: Brazil
- Summary: Regular Acquisition of Medicine (S) Belonging to the Group (S) Group: 09.S.01.X - other Ophthalmologicals, Group: 09.S.01.L - Ocular Vascular Disorder Agents, Group: 09.S.01.G - Decongestants and an ...
- BRT Ref No: 117146069
- Deadline: 14 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90067/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Regular Acquisition of Medicines (s) belonging to Group (s) Group: 09.S.01.X - Other Ophthalmologicals, Group: 09.S.01.L - Ocular Vascular Disorder Agents, Group: 09.S.01.G - DISCOGESTIONINGS AND OTHER GROUPS, IN PRICE REGISTRATION SYSTEMto the needs of the Health Secretariat DF, according to specifications and quantities contained in Annex I of the Notice.
UASG Code: 926119
Notice from: 02/04/2025 from 08:00 to 12:00 and from 13:00 to 17:59 HS
Proposal Delivery: From 04/02/2025 to 08:00 Retinol, Associated CompositionC/amino acids + methionine + chloramphenicol, 10.000UI concentration + 25mg + 5mg + 5mg/g, ophthalmic ointment application
Quantity: 1579
ranibizumab, concentration 10 mg/ml, pharmaceutical form injectable solution, additional characteristic w/application system
quantity: 315
ranibizumab, concentration 10Mg/ml, pharmaceutical form injectable solution, additional feature w/application system
quantity: 104
ketotiphene, fumarate composition, concentration 0.345 mg/ml, pharmaceutical form ophthalmic solution
quantity: 711
dexamethasone, dosage 0.1%, presentation ophthalmic solution
quantity:3260
ACICLOVIR, dosage 30 mg/g, use ophthalmic ointment
Quantity: 699
Proxmetacaine hydrochloride, dosage 0.5%, indication eye drops: 827
dextran, composition dextran 70 associated with hypromelose, 0.1% + 0.3%, formalized solution
quantity: 1919
acid Polyacrylic,Concentration 2 mg/g, ophthalmic gel presentation
quantity: 567
ciprofloxacin hydrochloride, dosage 3.5 mg/g, pharmaceutical form ophthalmic
quantity: 854
ciprofloxacin hydrochloride, dosage 3.5 mg/ml, pharmaceutical form ophthalmic solution
quantity
toobamicin, active ingredient associatedWith dexamethasone, dosage 0.3% + 0.1%, ophthalmic ointment presentation
quantity ... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRegular Acquisition of Medicine (S) Belonging to the Group (S) Group: 09.S.01.X - other Ophthalmologicals, Group: 09.S.01.L - Ocular Vascular Disorder Agents, Group: 09.S.01.G - Decongestants and an ... - Brazil Tender
The FEDERAL DISTRICT GOVERNMENT - GDF, a Government sector organization in Brazil, has announced a new tender for Regular Acquisition of Medicine (S) Belonging to the Group (S) Group: 09.S.01.X - other Ophthalmologicals, Group: 09.S.01.L - Ocular Vascular Disorder Agents, Group: 09.S.01.G - Decongestants and an .... This tender is published on BrazilTenders under BRT Ref No: 117146069 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-14.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
